Lus et élus

Autor: MF Pichon

Publikováno v: Immuno-analyse & Biologie Spécialisée. 11:141-143

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::18c84a82c0adf48370a1a804475cf338
https://doi.org/10.1016/0923-2532(96)87682-4

[Long-term prognostic role of steroid receptors in cancer of the breast]

Autor: Broët P, Mf, Pichon, Magdelenat H, Jc, Delarue, Spyratos F, Jp, Basuyau, Saez S, Rallet A, Courrière P, Millon R, Asselain B

Publikováno v: Europe PubMed Central

We screened for the prognostic value of estrogen receptor (ER) and progesterone receptor (PR) through a multicentric study of 2,257 operable breast cancer patients who did not received adjuvant therapy. Three hundred and seven local-regional recurren

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8e2f11f22d2e53958cb88c45f0994c17
https://pubmed.ncbi.nlm.nih.gov/9752299

Histopathological data - reply

Autor: MF Pichon

Publikováno v: British Journal of Cancer. 75:1854-1854

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c3b4dcb755a451298438720fa93556ec
https://doi.org/10.1038/bjc.1997.317

Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.

Autor: Oudard S; Department of Medical Oncology, Georges Pompidou Hospital, University Paris Descartes, Paris, France. Electronic address: stephane.oudard@egp.aphp.fr., Culine S; Department of Medical Oncology, Saint Louis Hospital, Paris, France., Vano Y; Department of Medical Oncology, Georges Pompidou Hospital, University Paris Descartes, Paris, France., Goldwasser F; Department of Medical Oncology, Cochin Hospital, Paris, France., Théodore C; Department of Medical Oncology, Foch Hospital, Suresnes, France., Nguyen T; Department of Medical Oncology, Besançon University Hospital, Besançon, France., Voog E; Department of Medical Oncology, Victor Hugo Clinic, Le Mans, France., Banu E; Department of Medical Oncology, Georges Pompidou Hospital, University Paris Descartes, Paris, France., Vieillefond A; Department of Medical Oncology, Cochin Hospital, Paris, France., Priou F; Department of Oncology-Hematology, La Roche-Sur-Yon Hospital, La Roche-Sur-Yon, France., Deplanque G; Department of Medical Oncology, Saint Joseph Foundation, Paris, France., Gravis G; Department of Medical Oncology, Paoli Calmettes Institute, Marseille, France., Ravaud A; Department of Medical Oncology, Bordeaux University Hospital, Bordeaux, France., Vannetzel JM; Department of Oncology, Clinique Hartman, Neuilly-sur-Seine, France., Machiels JP; Department of Medical Oncology, Saint Luc University Clinics, Catholic University of Leuven (IREC/MIRO, pole ONCO), Brussels, Belgium., Muracciole X; Department of Medical Oncology, La Timone Hospital, Marseille, France., Pichon MF; Oncobiology Laboratory, René Huguenin Center, St Cloud, France., Bay JO; Department of Oncology, Saint Perrin Hospital, Clermont Ferrand, France., Elaidi R; ARTIC Group (Association de Recherche sur les Thérapeutiques innovantes en Cancérologie), France., Teghom C; ARTIC Group (Association de Recherche sur les Thérapeutiques innovantes en Cancérologie), France., Radvanyi F; Molecular Oncology, Curie Institute, UMR 144, CNRS, Paris, France., Beuzeboc P; Department of Medical Oncology, Curie Institute, Paris, France.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2015 Jan; Vol. 51 (1), pp. 45-54. Date of Electronic Publication: 2014 Nov 15.

Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer.

Autor: Ali SM; Department of Hematology-Oncology, Penn State Hershey Cancer Center, Penn State University/Hershey Medical Center, Hershey, Pennsylvania 17033, USA., Carney WP, Esteva FJ, Fornier M, Harris L, Köstler WJ, Lotz JP, Luftner D, Pichon MF, Lipton A

Publikováno v: Cancer [Cancer] 2008 Sep 15; Vol. 113 (6), pp. 1294-301.